CIK 0000907654 · Non-accelerated filer<br>Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 363855489
- Phone
- 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- 8-K Event Shareholder vote results · Other events
- 4 Insider Changes in Ownership
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Other events
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement
- 425 Deal Prospectus/Communication re Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Results of operations
- 424B3 Offering Prospectus
- 10-Q Report Quarterly Report
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- 4 Insider Changes in Ownership
- EFFECT Other Notice of Effectiveness
- ARS Other Annual Report to Security Holders
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-4/A Deal Registration Statement - Business Combination
- UPLOAD Other SEC-generated Letter
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
Page 11 of 77 · 1,539 filings